Back to NBIX
KBC Group NV NBIX Position History
Neurocrine Biosciences, Inc. • Healthcare
Quarters held
10
Latest value
$969K
Q3 2026
Peak value
$58.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $2M |
| Q3 2025 | $20K |
| Q4 2025 | $4.6M |
| Q4 2025 | $20K |
| Q1 2026 | $2.2M |
| Q1 2026 | $18K |
| Q2 2026 | $2.8M |
| Q2 2026 | $41K |
| Q3 2026 | $58.4M |
| Q3 2026 | $969K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $969K | 6.8K | — | — |
| Q3 2026 | $58.4M | 411.7K | — | — |
| Q2 2026 | $41K | 245 | — | — |
| Q2 2026 | $2.8M | 16.9K | — | — |
| Q1 2026 | $18K | 139 | — | — |
| Q1 2026 | $2.2M | 16.9K | — | — |
| Q4 2025 | $20K | 139 | — | — |
| Q4 2025 | $4.6M | 32.3K | — | — |
| Q3 2025 | $20K | 139 | — | — |
| Q3 2025 | $2M | 14.4K | — | — |
Other funds holding NBIX
$1.3B
$1.3B
$1.2B
$1.1B
$997.5M
$967.6M
$941.2M
$917.9M